Last10K.com

Accellent Inc (1342505) SEC Filing 10-Q Quarterly report for the period ending Saturday, June 30, 2012

Accellent Inc

CIK: 1342505

Exhibit 99.1

Investor Contact: Jeremy Friedman

Executive Vice President and Chief Financial Officer

978 570 6900

Jeremy.friedman@accellent.com

FOR IMMEDIATE RELEASE

Accellent Inc. Announces Second Quarter 2012 Results

Wilmington, MA (August 9, 2012) – Accellent Inc. (the “Company” or “Accellent”), a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal second quarter ended June 30, 2012.

Second Quarter 2012 Financial Results

Net sales were $130.2 million in the second quarter of 2012 compared with $142.8 million in the second quarter of 2011. Income from operations was $13.7 million in the second quarter of 2012, compared with $19.4 million in the second quarter of 2011. Net loss was $5.6 million in the second quarter of 2012, compared with net income of $1.0 million in the second quarter of 2011.

Adjusted EBITDA for the second quarter of 2012 was $26.6 million, or 20.4% of net sales, compared to Adjusted EBITDA of $30.2 million, or 21.2% of net sales, in the second quarter of 2011.

“Challenging market conditions and comparisons to a record revenue quarter last year resulted in an 8.8% decline in our sales that directly impacted our profitability. In the second quarter, we continued to progress in our efforts to improve our business fundamentals to drive sustainable profitable growth and I am optimistic that our actions will generate positive results” stated Donald Spence, President and CEO of Accellent.

Six Months Ended June 30, 2012 Financial Results

Net sales decreased 4.0% to $261.8 million in the first six months of 2012 compared with $272.7 million in the first six months of 2011. Income from operations was $24.7 million in the first six months of 2012 compared with $32.4 million in the first six months of 2011. Net loss was $12.6 million in the first six months of 2012 compared with a net loss of $7.2 million in the first six months of 2011.

Adjusted EBITDA for the first six months of 2012 was $49.6 million, or 18.9% of net sales compared to Adjusted EBITDA of $54.1 million, or 19.8% of net sales in the first six months of 2011.


The following information was filed by Accellent Inc on Thursday, August 9, 2012 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Accellent Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accellent Inc.

Continue

Assess how Accellent Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Accellent Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
CIK: 1342505
Form Type: 10-Q Quarterly Report
Accession Number: 0001193125-12-355580
Submitted to the SEC: Tue Aug 14 2012 4:12:09 PM EST
Accepted by the SEC: Tue Aug 14 2012
Period: Saturday, June 30, 2012
Industry: Surgical And Medical Instruments And Apparatus

External Resources:

Bookmark the Permalink:
https://last10k.com/sec-filings/1342505/0001193125-12-355580.htm